silkis ointment 3 mcgg
galderma singapore private limited - calcitriol - ointment - 3 mcg/g - calcitriol 3 mcg/g
differin cream 0.1%
galderma singapore private limited - adapalene - cream - 0.10% - adapalene 0.1%
desowen cream 0.05%
galderma singapore private limited - desonide - cream - 0.05% - desonide 0.05%
desowen lotion 0.05%
galderma singapore private limited - desonide - lotion - 0.05% - desonide 0.05%
differin gel 0.1%
galderma singapore private limited - adapalene - gel - 0.1% w/w - adapalene 0.1% w/w
epiduo gel 0.1%2.5%
galderma singapore private limited - adapalene; benzoyl peroxide - gel - 0.10% - adapalene 0.10%; benzoyl peroxide 2.50%
soolantra 10mg/g cream
galderma (uk) ltd - ivermectin - cream - 10 milligram(s)/gram - other dermatologicals; ivermectin - other dermatological preparations, other dermatologicals - it is indicated for the topical treatment of inflammatory lesions of rosacea (papulopustular) in adult patients
soolantra ivermectin 10 mg/g cream tube
galderma australia pty ltd - ivermectin, quantity: 10 mg/g - cream - excipient ingredients: glycerol; isopropyl palmitate; carbomer copolymer (type b); dimeticone 20; disodium edetate; citric acid monohydrate; cetyl alcohol; stearyl alcohol; ceteareth-20; sorbitan stearate; methyl hydroxybenzoate; propyl hydroxybenzoate; phenoxyethanol; propylene glycol; oleyl alcohol; sodium hydroxide; purified water - soolantra is indicated for the topical treatment of inflammatory lesions of rosacea (papulo-pustular) in adult patients 18 years and over.
epiduo 0.1%/2.5% adapalene / benzoyl peroxide gel bottle
galderma australia pty ltd - adapalene, quantity: 1 mg/g; benzoyl peroxide, quantity: 25 mg/g - gel - excipient ingredients: poloxamer; docusate sodium; purified water; glycerol; disodium edetate; propylene glycol; polysorbate 80; acrylamide/sodium acryloyldimethyltaurate copolymer; isohexadecane; sorbitan oleate - cutaneous treatment of acne vulgaris on the face, chest and back when comedones, papules and pustules are present, and the condition has not responded to first line treatment.
mirvaso brimonidine 3.3 mg/g (as tartrate) gel tube
galderma australia pty ltd - brimonidine tartrate, quantity: 5 mg/g (equivalent: brimonidine, qty 3.3 mg/g) - gel - excipient ingredients: carbomer 974p; methyl hydroxybenzoate; phenoxyethanol; glycerol; titanium dioxide; propylene glycol; sodium hydroxide; purified water - mirvaso is indicated for the treatment of facial erythema of rosacea in adult patients